Maddalena Adorno

Maddalena Adorno is a scientist who discovered a program of rejuvenation in human cells, starting from the study of Down syndrome in 2013. This discovery has received recognition and funding from institutions such as the California Institute for Regenerative Medicine. Later, he founded Dorian Therapeutics, a startup in Silicon Valley, with the goal of developing drugs that reactivate youth programs in human tissues. Now, at the age of 40, he is preparing for the first clinical trial and wants to move part of the research activities to Italy.